Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-006287

CVP, Chief Financial Officer sold 5,625 shares at $90.45 ($508,803)

  • CVP, Chief Financial Officer acquired 5,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ullem Scott B. CVP, Chief Financial Officer 2024-05-21 Option exercise 10b5-1 +5,625 $45.28 $254,681 36,186 D: show line 1 in the form
Ullem Scott B. CVP, Chief Financial Officer 2024-05-21 Sale 10b5-1 −5,625 $90.45 $508,803 30,561 D: show line 2 in the form
Open-market sales · 5,625 sh · avg $90.45 · $508,803

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Ullem Scott B. CVP, Chief Financial Officer 2024-05-21 Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 −5,625 61,875 D: show line 3 in the form
Loading xslF345X05/doc4.xml…